Emergex
  • About Us
      • Team
      • Board of Directors
      • Special Advisors
      • Partners
  • Technology
      • Advantages of Emergex’s Vaccines
  • Pipeline
  • Media Centre
    • In the News
    • Press Releases
  • Careers
  • Contact Us
  • Menu Menu
You are here: Home1 / Media Centre2 / Press Releases3 / In the news

In the News

Please find below a selection of recent media coverage in which the Emergex Vaccines story is featured.

Advancing immunology: the future of vaccine innovations

07 June 2023

Read more

European Pharmaceutical Review: Anatomy of a ‘correlate of protection’ for T-cell vaccines

16 June 2022

Read more

Access the journal

NanoPass’s intradermal delivery platform used in Emergex’s next generation COVID-19 vaccination study

26 January 2022

Read more

The Guardian – As Covid mutates, the vaccine makers are adapting too

11 December 2021

Read more

The Guardian – UK firm to trial T-cell Covid vaccine that could give longer immunity

15 November 2021

Read more

The Guardian – Covid live: Egypt starts vaccine trial; Austria to put unvaccinated people in lockdown

14 November 2021

Read more

CNBC news interview with Emergex Vaccines CEO, Professor Thomas Rademacher

14 May 2018

© EMERGEX VACCINES

Website maintained by Digital Trading

  • Contact Us
LinkedIn
Scroll to top